Source comparison
Melanotan-2 Benefits: Clinical vs Research Comparison
The following table distinguishes established research findings from preliminary observations requiring further investigation, clarifying which Melanotan-2 benefits rest on robust evidence and which remain speculative. Eumelanin synthesis and pigmentation MC1R
This comparison does not assign a generated winner or score.
- The following table distinguishes established research findings from preliminary observations requiring further investigation, clarifying which Melanotan-2 benefits rest on robust evidence and which remain speculative.
- Eumelanin synthesis and pigmentation
- MC1R
- Established. Multiple RCTs, dose-response confirmed
- Photoprotection studies, melanogenesis pathway research, comparison with natural UV tanning
- Strongest evidence base. Mechanism fully characterized through cAMP-CREB-MITF pathway. Dose-dependent and reproducible across skin types.
- Appetite suppression and caloric intake reduction
- MC4R
- Strong. Replicated in human trials, mechanistic understanding clear
- Obesity research models, hypothalamic appetite circuit mapping, neuropeptide interaction studies
- Well-documented 15-30% intake reduction. Effect sustained over 28 days. Mediated through POMC/AgRP neuron populations.
- Thermogenesis and energy expenditure increase
- Moderate. Consistent rodent data, limited human validation
- Brown adipose tissue activation studies, sympathetic nervous system research, metabolic rate measurement
- Rodent models show 12-18% oxygen consumption increase. Human data sparse. UCP1 upregulation mechanism identified.
- Insulin sensitivity improvement
- Moderate. Demonstrated in clamp studies (rodents), preliminary human data
- Type 2 diabetes models, GLUT4 translocation research, PI3K-Akt pathway studies
- 22% glucose disposal increase in obese mice. Weight-independent component confirmed. Human trials needed.
- Lipolysis and adipose tissue reduction
- Moderate. Observed in chronic dosing studies, mechanism partially characterized
- Visceral fat reduction models, HSL/FAS expression research, body composition studies
- 18-24% visceral fat loss beyond pair-fed controls. Free fatty acid mobilization confirmed. Chronic dosing data only.
- Photoprotection and DNA damage reduction
- Moderate. Strong in vitro and animal data, human RCT data incomplete
- UV-induced carcinogenesis research, DNA repair pathway studies, keratinocyte protection models
- 40-55% CPD reduction in cell culture. 64% tumor reduction in SKH-1 mice. Human photoprotection trials incomplete.
- Inflammatory cytokine modulation
- MC1R, MC3R
- Preliminary. Limited studies, mechanism under investigation
- Inflammatory disease models, adipose tissue inflammation, immune cell signaling
- Early data show TNF-α and IL-6 reductions in adipocytes. Receptor subtype contributions unclear. Requires replication.